NDC 10544-292

Doxazosin Mesylate

Doxazosin Mesylate

Doxazosin Mesylate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Blenheim Pharmacal, Inc.. The primary component is Doxazosin Mesylate.

Product ID10544-292_2892f3c2-bff6-4411-adf3-fa065ac7c362
NDC10544-292
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin Mesylate
Generic NameDoxazosin Mesylate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-12-10
Marketing CategoryANDA / ANDA
Application NumberANDA076161
Labeler NameBlenheim Pharmacal, Inc.
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 10544-292-90

90 TABLET in 1 BOTTLE (10544-292-90)
Marketing Start Date2013-12-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10544-292-90 [10544029290]

Doxazosin Mesylate TABLET
Marketing CategoryANDA
Application NumberANDA076161
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-12-10
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DOXAZOSIN MESYLATE4 mg/1

OpenFDA Data

SPL SET ID:2892f3c2-bff6-4411-adf3-fa065ac7c362
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197625
  • 197627
  • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Doxazosin Mesylate" or generic name "Doxazosin Mesylate"

    NDCBrand NameGeneric Name
    68258-6099Doxazosin MesylateDoxazosin Mesylate
    70518-0398Doxazosin mesylateDoxazosin mesylate
    70518-0184Doxazosin MesylateDoxazosin Mesylate
    71610-120Doxazosin mesylateDoxazosin mesylate
    71610-110Doxazosin mesylateDoxazosin mesylate
    10544-292Doxazosin MesylateDoxazosin Mesylate
    10544-629Doxazosin MesylateDoxazosin Mesylate
    43353-646Doxazosin MesylateDoxazosin Mesylate
    43353-740Doxazosin MesylateDoxazosin Mesylate
    43353-739Doxazosin MesylateDoxazosin Mesylate
    50090-0735Doxazosin MesylateDoxazosin Mesylate
    50090-1591Doxazosin MesylateDoxazosin Mesylate
    53808-0361Doxazosin MesylateDoxazosin Mesylate
    53808-1107Doxazosin MesylateDoxazosin Mesylate
    53808-0362Doxazosin MesylateDoxazosin Mesylate
    53808-1017Doxazosin mesylateDoxazosin mesylate
    59762-2380Doxazosin mesylateDoxazosin mesylate
    59762-2340Doxazosin mesylateDoxazosin mesylate
    59762-2310Doxazosin mesylateDoxazosin mesylate
    59762-2320Doxazosin mesylateDoxazosin mesylate
    60429-956Doxazosin MesylateDoxazosin Mesylate
    60429-954Doxazosin MesylateDoxazosin Mesylate
    60429-955Doxazosin MesylateDoxazosin Mesylate
    60429-953Doxazosin MesylateDoxazosin Mesylate
    67253-380Doxazosin MesylateDoxazosin Mesylate
    67253-383Doxazosin MesylateDoxazosin Mesylate
    67253-381Doxazosin MesylateDoxazosin Mesylate
    67253-382Doxazosin MesylateDoxazosin Mesylate
    71610-251Doxazosin mesylateDoxazosin mesylate
    0049-2710Carduradoxazosin mesylate
    0049-2720Carduradoxazosin mesylate
    0049-2750Carduradoxazosin mesylate
    0049-2760Carduradoxazosin mesylate
    0049-2770Carduradoxazosin mesylate
    0049-2780Carduradoxazosin mesylate
    0093-2067DoxazosinDoxazosin Mesylate
    0093-2068DoxazosinDoxazosin Mesylate
    0093-2069DoxazosinDoxazosin Mesylate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.